|
|
,
Add to My Group(s)
Add to My Group(s)
By Evelyn Pringle (about the author)
Become a Fan (1 fan) -- Page 3 of 6 page(s)
Before the meeting ended, McGuire passed a notebook around the audience to solicit names of NAMI members who would be willing to be respond if there was a parental uprising against TeenScreen in their community. She explained that they might be asked to write a letter to the editor or go to a school board meeting, things like that.
TeenScreen has many supporting front groups listed in its informational material. Another example of a funnel is the Depression and Bipolar Support Alliance which reports pharma financial backing equal to 53% of all revenue. According to its 2001 Annual Report, drug companies which donate between $150,000 and $499,999, include Abbot, Bristol-Meyers-Squibb, Eli Lilly, Pfizer, Glaxo-Kline, and Janssen. In addition, nearly all of the other major drug makers donate a lesser amount.
Another favorite mantra by TeenScreen officials is that the program is free and it doesn't get any government money. Well, something went haywire with the "free" mental health check-up business because, according to a July 11, 2005, article in the Peoria Illinois Journal Star, in Brimfield Illinois, "organizing the system and employing a part-time counselor specifically for the program is estimated to cost about $100 per student."
Overall, the "Brimfield High School program alone will cost around $20,000 for the first semester," the Journal wrote.
Let me repeat that so tax payers "get it," that is $20,000 tax dollars per semester to run this marketing scheme for pharma.
In Florida, according to a June 5, 2003 Weekly Planet article, Gwen Luney, assistant superintendent for supportive services for the Hillsborough County Schools, said TeenScreen would cost the school district roughly $200,000 a year.
Drugging Kids With Lethal Medications
On June 18, 2003, GlaxSmithKline issued a warning to British physicians against the use of Paxil in children, and acknowledged its failure in clinical trials "to demonstrate efficacy in major depressive disorders and doubling the rate of reported adverse events - including suicidal thoughts and suicide attempts - compared to placebo."
On December 18, 2003, Eli Lilly issued letters to British healthcare professionals, indicating that Prozac is not recommended for children - for any use.
The results of a recent study conducted at the Ottawa Health Research Institute were published in the February 2005 British Medical Journal. The study reviewed over 700 clinical trials involving 87,650 patients, and provided an all-inclusive look at the suicide risk with SSRIs, because it counted suicide attempts by subjects treated for a variety of conditions in addition to depression, including panic disorder, bulimia, and sexual dysfunction.
The study determined that patients taking SSRIs are more than twice as likely to attempt suicide as patients given placebos. The fact that there is a increased risk of suicide attempts for patients who were not depressed and were being treated for other kinds of disorders is highly significant.
Most of the drugs being pushed on kids are not approved for kids but even if they were it wouldn't mean much. What most people don 't realize is that to gain FDA approval, a company is not required to prove that a new drug is safer or more effective than an older drug. All it has to do is show that a drug provided better results than a placebo in short-term trial of often only 6 to 8 weeks, with a statistically significant group of patients, according to Bob Whitaker, investigative journalist and author of Mad In America.
We know these drugs are very dangerous. Nevertheless, there has been a very large increase in the numbers of children placed on SSRIs in the United States. Not only that, the fastest growing segment of users are age 0-5, reported Dr John Breeding, PhD, Director of Texans For Safer Education, and author of, The Necessity of Unproductivity and Madness, and The Wildest Colts Make The Best Horses, during Testimony to Texas House Select Committee, on October 4, 2004.
He called for a ban on the use of SSRIs for children and warned, "SSRIs are extremely harmful and addictive; and can cause or exacerbate suicidal or homicidal tendencies; withdrawal is painful and dangerous."
Psychiatrist Peter Breggin, a court-qualified medical expert, and author of books, Talking Back to Prozac and The Anti-Depressant Fact Book, The Ritalin Fact Book, warns about the life-long damage a label of mentally illness can cause.
"There is nothing worse that you can do to a human being in America today than give them a mental illness kind of label and tell them they need drugs and these children are 3, 4, 5, 6, 7, 8, 9 years-old being treated in this manner," Breggin reports.
Become a Fan (1 fan) -- Page 3 of 6 page(s)
TeenScreen has many supporting front groups listed in its informational material. Another example of a funnel is the Depression and Bipolar Support Alliance which reports pharma financial backing equal to 53% of all revenue. According to its 2001 Annual Report, drug companies which donate between $150,000 and $499,999, include Abbot, Bristol-Meyers-Squibb, Eli Lilly, Pfizer, Glaxo-Kline, and Janssen. In addition, nearly all of the other major drug makers donate a lesser amount.
Another favorite mantra by TeenScreen officials is that the program is free and it doesn't get any government money. Well, something went haywire with the "free" mental health check-up business because, according to a July 11, 2005, article in the Peoria Illinois Journal Star, in Brimfield Illinois, "organizing the system and employing a part-time counselor specifically for the program is estimated to cost about $100 per student."
Overall, the "Brimfield High School program alone will cost around $20,000 for the first semester," the Journal wrote.
Let me repeat that so tax payers "get it," that is $20,000 tax dollars per semester to run this marketing scheme for pharma.
In Florida, according to a June 5, 2003 Weekly Planet article, Gwen Luney, assistant superintendent for supportive services for the Hillsborough County Schools, said TeenScreen would cost the school district roughly $200,000 a year.
Drugging Kids With Lethal Medications
On June 18, 2003, GlaxSmithKline issued a warning to British physicians against the use of Paxil in children, and acknowledged its failure in clinical trials "to demonstrate efficacy in major depressive disorders and doubling the rate of reported adverse events - including suicidal thoughts and suicide attempts - compared to placebo."
On December 18, 2003, Eli Lilly issued letters to British healthcare professionals, indicating that Prozac is not recommended for children - for any use.
The results of a recent study conducted at the Ottawa Health Research Institute were published in the February 2005 British Medical Journal. The study reviewed over 700 clinical trials involving 87,650 patients, and provided an all-inclusive look at the suicide risk with SSRIs, because it counted suicide attempts by subjects treated for a variety of conditions in addition to depression, including panic disorder, bulimia, and sexual dysfunction.
The study determined that patients taking SSRIs are more than twice as likely to attempt suicide as patients given placebos. The fact that there is a increased risk of suicide attempts for patients who were not depressed and were being treated for other kinds of disorders is highly significant.
Most of the drugs being pushed on kids are not approved for kids but even if they were it wouldn't mean much. What most people don 't realize is that to gain FDA approval, a company is not required to prove that a new drug is safer or more effective than an older drug. All it has to do is show that a drug provided better results than a placebo in short-term trial of often only 6 to 8 weeks, with a statistically significant group of patients, according to Bob Whitaker, investigative journalist and author of Mad In America.
We know these drugs are very dangerous. Nevertheless, there has been a very large increase in the numbers of children placed on SSRIs in the United States. Not only that, the fastest growing segment of users are age 0-5, reported Dr John Breeding, PhD, Director of Texans For Safer Education, and author of, The Necessity of Unproductivity and Madness, and The Wildest Colts Make The Best Horses, during Testimony to Texas House Select Committee, on October 4, 2004.
He called for a ban on the use of SSRIs for children and warned, "SSRIs are extremely harmful and addictive; and can cause or exacerbate suicidal or homicidal tendencies; withdrawal is painful and dangerous."
Psychiatrist Peter Breggin, a court-qualified medical expert, and author of books, Talking Back to Prozac and The Anti-Depressant Fact Book, The Ritalin Fact Book, warns about the life-long damage a label of mentally illness can cause.
"There is nothing worse that you can do to a human being in America today than give them a mental illness kind of label and tell them they need drugs and these children are 3, 4, 5, 6, 7, 8, 9 years-old being treated in this manner," Breggin reports.
The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.
 Contact Author |
Contact Editor |
 View Authors' Articles |
Comments
The time limit for entering new comments on this article has expired.
This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.
| No comments |